Barclays PLC Agios Pharmaceuticals, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Barclays PLC holds 180,417 shares of AGIO stock, worth $10 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

180,417

Previous 180,417 -0.0%

Holding current value

$10 Million

Previous $8.02 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$41.19 - $49.72 $2.91 Million - $3.51 Million	70,536 Added 64.19%	180,417 $8.02 Million
Q2 2024 Aug 14, 2024	BUY	$27.55 - $48.83 $1.12 Million - $1.99 Million	40,655 Added 58.73%	109,881 $4.74 Million
Q1 2024 May 15, 2024	SELL	$21.32 - $34.81 $1.82 Million - $2.98 Million	-85,510 Reduced 55.26%	69,226 $2.03 Million
Q4 2023 Feb 15, 2024	BUY	$19.97 - $24.53 $673,548 - $827,347	33,728 Added 27.87%	154,736 $3.45 Million
Q3 2023 Nov 07, 2023	SELL	$24.36 - $28.18 $918,786 - $1.06 Million	-37,717 Reduced 23.76%	121,008 $2.99 Million
Q2 2023 Aug 03, 2023	BUY	$21.38 - $29.19 $1.34 Million - $1.84 Million	62,896 Added 65.63%	158,725 $4.5 Million
Q1 2023 May 04, 2023	SELL	$21.74 - $30.93 $703,962 - $1 Million	-32,381 Reduced 25.26%	95,829 $2.2 Million
Q4 2022 Feb 13, 2023	BUY	$24.81 - $31.52 $811,535 - $1.03 Million	32,710 Added 34.25%	128,210 $3.6 Million
Q3 2022 Nov 03, 2022	BUY	$19.51 - $34.14 $1.48 Million - $2.6 Million	76,080 Added 391.76%	95,500 $2.7 Million
Q2 2022 Aug 12, 2022	SELL	$17.06 - $31.42 $792,607 - $1.46 Million	-46,460 Reduced 70.52%	19,420 $431,000
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $104,985 - $136,977	-3,935 Reduced 5.64%	65,880 $1.92 Million
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $1.28 Million - $2.16 Million	43,391 Added 164.21%	69,815 $2.3 Million
Q3 2021 Nov 09, 2021	SELL	$41.92 - $58.18 $1.13 Million - $1.57 Million	-26,954 Reduced 50.5%	26,424 $1.22 Million
Q2 2021 Aug 13, 2021	SELL	$52.06 - $61.27 $2.04 Million - $2.4 Million	-39,241 Reduced 42.37%	53,378 $2.94 Million
Q1 2021 May 13, 2021	SELL	$44.23 - $57.5 $832,718 - $1.08 Million	-18,827 Reduced 16.89%	92,619 $4.78 Million
Q4 2020 Feb 11, 2021	SELL	$33.21 - $46.54 $108,032 - $151,394	-3,253 Reduced 2.84%	111,446 $4.83 Million
Q3 2020 Nov 12, 2020	BUY	$33.87 - $55.93 $292,196 - $482,508	8,627 Added 8.13%	114,699 $4.02 Million
Q2 2020 Aug 12, 2020	SELL	$34.45 - $53.48 $135,629 - $210,550	-3,937 Reduced 3.58%	106,072 $5.67 Million
Q1 2020 May 13, 2020	BUY	$31.52 - $53.81 $2.72 Million - $4.65 Million	86,447 Added 366.89%	110,009 $3.9 Million
Q4 2019 Feb 10, 2020	BUY	$30.08 - $50.59 $606,803 - $1.02 Million	20,173 Added 595.25%	23,562 $1.13 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $2.51 Million - $3.84 Million	-77,532 Reduced 95.81%	3,389 $110,000
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $3.57 Million - $5.27 Million	77,423 Added 2213.35%	80,921 $4.04 Million
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $33,108 - $48,790	-721 Reduced 17.09%	3,498 $236,000
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $11,836 - $21,198	-277 Reduced 6.16%	4,219 $195,000
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $6,091 - $7,815	-85 Reduced 1.86%	4,496 $347,000
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $183,050 - $248,875	-2,500 Reduced 35.31%	4,581 $386,000
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $1.01 Million - $1.47 Million	-16,949 Reduced 70.53%	7,081 $580,000
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $245,276 - $340,384	-4,706 Reduced 16.38%	24,030 $1.37 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $1.58 Million - $1.93 Million	28,736	28,736 $1.92 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account